“Ecstasy” use remains highest in high income countries and parts of Asia.Past-year use of "ecstasy" globally is estimated at 0.4 per cent among those aged 15-64. Use is higher among men (0.54 per cent) than women (0.26 per cent), but the difference is not as pronounced as for other drugs (for…
Australia and New Zealand have the highest global annual prevalence of use of "ecstasy", where it is mostly used in capsule and crystal form.In Australia, the use and availability of "ecstasy" declined during the COVID-19 pandemic but have started to increase again in 2023 (while not yet reaching…
“Ecstasy” use remains concentrated in Europe (mainly Western and Central Europe)Use is significantly higher in Western and Central Europe than in Eastern and South-Eastern Europe, both in terms of prevalence (1.2 per cent vs. 0.4 per cent) and number of users (nearly 4 million versus less than 800,…
Global opiate use has remained broadly stable, with slight declines in the prevalence of use.The number of people using opiates worldwide has remained stable over the last five years, while the annual prevalence of use declined slightly from 0.61 per cent in 2020 to 0.57 per cent in 2023 and 2024.…
Global opioid use has remained broadly stable, with strong regional differences in prevalence of use.The number of people who use opioids worldwide has remained relatively stable in the last five years, with the estimate for 2024 only slightly higher than the level in 2019.Prevalence of past-year…
Drug-related deaths continue to rise globally, with indirect causes accounting for most harm.The total global number of deaths directly or indirectly attributable to drugs continued to increase in 2023, although population-adjusted rates have grown more slowly, suggesting that the growth was in…
Global drug use continues to increase, driven by rising prevalence of use and population growth.An estimated 331 million people used a drug in the past 12 months in 2024, a 34 per cent increase since 2014 (with prevalence of use increasing by 20 per cent).Men account for the majority of users (249…
Cannabis remains the most widely used drug globally, with large differences across substances and regions.With an estimated 256 million users in 2024, cannabis remains by far the most used drug worldwide, followed by the non-medical use of opioids at 63 million.Men have a higher prevalence of drug…
The illicit ketamine market has expanded beyond Asia, with rising use and emerging harms in new regions.Once concentrated in East and South-East Asia, several countries with time-series data (for example, the United Kingdom, Australia or the United States) have recorded an increase in the use of…
Countries differ in how they legislate to regulate or control drug use, though criminalization is common for key activities.About 38 per cent of reporting countries classify personal drug use as a criminal offence, with this approach most common in Africa and Asia. By contrast, related activities…
Cannabis use remains widespread globally, with steady long-term growth.Prevalence of past-year cannabis use is highest in North America, Australia and New Zealand, and West and Central Africa, while North America and South Asia have the highest number of people who use cannabis.Cannabis use has…
Cocaine use and related harms have increased globally over the past two decades, despite recent disruptions.Approximately 25 million people worldwide are estimated to have used cocaine in 2024 (or 0.47 per cent of the population aged 15-64), with lower estimated use among women (0.24 per cent) than…
